Actively Recruiting

Age: 18Years - 65Years
All Genders
NCT07259668

Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns

Led by Efferon JSC · Updated on 2026-01-22

15

Participants Needed

1

Research Sites

120 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This observational pilot study aims to establish criteria for evaluating the effectiveness of hemoadsorption with the Efferon LPS device in adult patients with burn injury. Participants will be prospectively enrolled into the treatment group and compared with a retrospectively selected control group. Each patient in the treatment group will undergo two hemoadsorption sessions, each lasting 6-12 hours, with a 24 hours interval between sessions. The procedures may be performed in combination with hemofiltration or hemodiafiltration at the investigator's discretion.

CONDITIONS

Official Title

Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 65 years
  • Thermal burn of severity I and II with lesion area of 40% or more (ICD-10: T20-T25, T29)
  • Burn disease in the stage of acute toxemia or septicemia
  • Frank Index equal or greater than 90
  • Patient's condition allows for at least 6 hours of Efferon LPS therapy
Not Eligible

You will not qualify if you...

  • Isolated thermal inhalation injury
  • Charlson Comorbidity Index greater than 8
  • Dementia
  • End-stage renal failure
  • Acute pulmonary embolism confirmed by CT
  • Acute myocardial infarction within the past 4 weeks
  • Acute cerebrovascular accident
  • Uncontrolled bleeding within the past 24 hours
  • Any other condition making the patient unsuitable according to the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

State Novosibirsk Regional Clinical Hospital

Novosibirsk, Russia, 630087

Actively Recruiting

Loading map...

Research Team

A

Alexandr Shelehov-Kravchenko, PhD, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here